Request Demo
Last update 17 Apr 2025
Dodekin (Philogen)
Last update 17 Apr 2025
Overview
Basic Info
Drug Type Monoclonal antibody |
Synonyms IL12 L19L19, IL12-L19-L19, IL12-L19L19 + [1] |
Target |
Action inhibitors, stimulants |
Mechanism EDB-FN inhibitors(Human fibronectin extra domain B inhibitors), IL-12R stimulants(Interleukin-12 receptor stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with Dodekin (Philogen)NCT04471987
A Phase I Study to Evaluate Safety and Early Signs of Efficacy of the Human Monoclonal Antibody-cytokine Fusion Protein IL12-L19L19.
100 Clinical Results associated with Dodekin (Philogen)
Login to view more data
100 Translational Medicine associated with Dodekin (Philogen)
Login to view more data
100 Patents (Medical) associated with Dodekin (Philogen)
Login to view more data
100 Deals associated with Dodekin (Philogen)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 1 | Germany | 01 Jul 2020 | |
| Advanced Malignant Solid Neoplasm | Phase 1 | Italy | 01 Jul 2020 | |
| Advanced Malignant Solid Neoplasm | Phase 1 | Switzerland | 01 Jul 2020 | |
| Metastatic Solid Tumor | Phase 1 | Germany | 01 Jul 2020 | |
| Metastatic Solid Tumor | Phase 1 | Italy | 01 Jul 2020 | |
| Metastatic Solid Tumor | Phase 1 | Switzerland | 01 Jul 2020 | |
| Diffuse Large B-Cell Lymphoma | Phase 1 | Italy | 21 Jun 2020 | |
| Neoplasms | Preclinical | Switzerland | 01 Jul 2018 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 1 | 20 | aauohnrjzn(tdbavomvrw) = One patient in cohort 3 (0.5 μg/kg) developed a DLT (G3 transient AST/ALT increase) zkgunquffx (chebshuymx ) View more | Positive | 26 Feb 2024 |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free